Recent HIV/AIDS News from CDC, NIH, and FDA

News from CDC May 21, 2014: New CDC Campaign Inspires Life-Saving Conversations About HIV “The Centers for Disease Control and Prevention today launched Start Talking. Stop HIV., a new national communication campaign encouraging gay and bisexual men to talk openly with their sexual partners about HIV risk and prevention strategies.” News from NIH May 19, 2014: 2014 Avant-Garde Awards Focus on Strengthening the Immune System “With proposals ranging from enhancing the immune system’s ability to fight HIV infection to improving long-term immune health in HIV-infected drug users, three scientists have been chosen to receive the 2014 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.”  News from FDA May 12, 2014: Tivicay (Dolutegravir) Labeling Update “On May 12, 2014, FDA approved updates to the TIVICAY (dolutegravir) product labeling with information regarding the effect of dolutegravir on renal transporters and drug-drug interaction data between dolutegravir and calcium carbonate or ferrous fumarate.” View the AIDSinfo patient fact sheet on dolutegravir.